Share of Gain or Loss on Investment in Associate
In April 2020, the Bank subscribed for a 30% economic interest in an entity incorporated in Singapore (the “Associate”), thereby giving the Bank significant influence over the financial and operating decisions of the Associate. Share of gain or loss on investment in associate reflects AIIB’s share in the gain or loss recognized by the Associate in the respective period.
Six Months Ended June 30, 2023 and 2022. AIIB’s share of gain on investment in associate for the six months ended June 30, 2023 was US$2.1 million. The share of gain on investment in associate for the six months ended June 30, 2022 was US$0.7 million. The share of gain on investment in associate for the six months ended June 30, 2023 mainly resulted from higher operating income generated by the Associate.
Impairment Provision
AIIB uses an expected credit loss (“ECL”) model to estimate credit losses on financial assets, such as loan disbursements or bond investments, and on other instruments, such as undrawn loan commitments. AIIB recognizes an ECL allowance at each reporting date and recognizes an impairment provision (either an impairment loss or the reversal of an impairment loss) that reflects the change in the ECL allowance between such reporting date and the previous reporting date. Impairment provisions are driven in large part by changes in loan volumes, risk parameters related to macroeconomic outlook and changes in AIIB’s assessment of the credit risk of individual financings.
Six Months Ended June 30, 2023 and 2022. AIIB’s impairment provision was US$36.9 million for the six months ended June 30, 2023, compared to US$152.6 million for the six months ended June 30, 2022.
The impairment provision recognized in the six months ended June 30, 2023 was mainly due to (i) an increase in outstanding loan volumes and (ii) changes in the risk parameters of certain sovereign-backed and non-sovereign-backed loans.
The impairment provision recognized in the six months ended June 30, 2022 was mainly due to (i) increases in the credit risks associated with certain non-sovereign-backed loans; (ii) the assessment as credit impaired of seven bond investments in the fixed-income portfolio, which comprises primarily Asian infrastructure-related bonds, and their transfer to Stage 3; and (iii) an increase in outstanding loan volumes.
General and Administrative Expenses
General and administrative expenses mainly consist of (i) staff costs, such as short-term employee benefits, including salaries, location premiums and medical and life insurance, and costs related to AIIB’s defined contribution (i.e., retirement) plans; (ii) professional service expenses; (iii) IT services; (iv) issuance cost in respect of borrowings; (v) facilities and administration expenses; (vi) travel expenses; and (vii) other expenses.
Six Months Ended June 30, 2023 and 2022. AIIB’s general and administrative expenses increased to US$103.6 million for the six months ended June 30, 2023 from US$83.5 million for the six months ended June 30, 2022, mainly due to an increase in staff costs, professional service expenses, costs related to IT, issuance cost for borrowings and travel expenses. Mainly as the result of the continuing ramp-up of AIIB’s organizational activities, staff costs increased to US$55.8 million for the six months ended June 30, 2023 from US$46.0 million for the six months ended June 30, 2022 and professional service expenses increased to US$15.3 million for the six months ended June 30, 2023 from US$13.9 million for the six months ended June 30, 2022. Costs related to IT services increased to US$9.0 million for the six months ended June 30, 2023 from US$8.8 million for the six months ended June 30, 2022. Issuance cost for borrowings increased to US$6.9 million for the six months ended June 30, 2023 from US$2.8 million for the six months ended June 30, 2022 due to an increase in the amount of issuances in the six months ended June 30, 2023 compared to the six months ended June 30, 2022. Mainly as a result of the gradual lifting of travel restrictions put in place in response to the COVID-19 pandemic, costs related to travel expenses increased to US$4.7 million for the six months ended June 30, 2023 from US$1.1 million for the six months ended June 30, 2022.
Net Foreign Exchange Loss or Gain
Net foreign exchange loss or gain reflects the change in value, due to movements in currency exchange rates, of financial instruments held by the Bank that are measured at amortized cost. For financial instruments held by the Bank measured at fair value through profit or loss, the change in value due to movements in currency exchange rates is reported as part of their overall change in fair value through profit or loss. See “–Net Gain on Financial Instruments Measured at Fair Value through Profit or Loss.”
Six Months Ended June 30, 2023 and 2022. AIIB had a net foreign exchange loss of US$60.3 million for the six months ended June 30, 2023, compared to a net foreign exchange gain of US$22.1 million for the six months ended June 30, 2022. The net foreign exchange loss for the six months ended June 30, 2023 was mainly due to foreign exchange losses from the depreciation of the Russian ruble, Turkish lira and Chinese yuan against the U.S. dollar and the impact such depreciations had on the U.S. dollar value of the Bank’s local currency loans (as recorded under the line item “Net Gain on Financial Instruments Measured at Fair Value through Profit or Loss”). These losses were partially offset by foreign exchange gains deriving from fair value movements on financial instruments held by the Bank to mitigate currency risks, namely, swaps. The net foreign exchange gain for the six months ended June 30, 2022 was mainly due to the appreciation of the Russian ruble against the U.S. dollar and the impact such appreciation had on the U.S. dollar value of the Bank’s exposure to a Russian ruble-denominated loan. Such net foreign exchange gain for the six months ended June 30, 2022 was largely offset, however, by foreign exchange losses deriving from the depreciation of the Euro and the Chinese yuan against the U.S. dollar and the impact such depreciations had on the U.S. dollar value of the Bank’s portfolio of Euro-denominated and Chinese yuan-denominated loans, as well as fair value movements on financial instruments held by the Bank to mitigate currency risks, namely, swaps.
10